Shenzhen Zhijun Pharmaceutical Co. Ltd., commonly referred to as Zhijun Pharma, is a leading player in the pharmaceutical industry, headquartered in Shenzhen, China. Established in 2005, the company has rapidly expanded its operations across major regions in Asia, focusing on the development and manufacturing of high-quality pharmaceutical products. Zhijun Pharma specialises in a diverse range of therapeutic areas, including oncology, cardiology, and infectious diseases. Their commitment to innovation is evident in their unique formulations and advanced drug delivery systems, which set them apart in a competitive market. With a strong emphasis on research and development, Zhijun Pharma has achieved significant milestones, positioning itself as a trusted name in the pharmaceutical sector. The company continues to strive for excellence, contributing to global health with its effective and reliable healthcare solutions.
How does Shenzhen Zhijun Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shenzhen Zhijun Pharmaceutical Co. Ltd's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shenzhen Zhijun Pharmaceutical Co. Ltd, headquartered in China, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Shanghai Shyndec Pharmaceutical Co., Ltd., which may influence its climate commitments and reporting practices. As of now, Shenzhen Zhijun Pharmaceutical has not established any documented reduction targets or climate pledges. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the pharmaceutical industry, which is increasingly focusing on sustainability and carbon reduction, it is essential for Shenzhen Zhijun Pharmaceutical to align with industry standards and best practices. This includes potentially adopting science-based targets and engaging in initiatives that promote transparency in emissions reporting. In summary, while Shenzhen Zhijun Pharmaceutical Co. Ltd has not disclosed any emissions data or reduction commitments, its affiliation with Shanghai Shyndec Pharmaceutical Co., Ltd. may provide a framework for future climate action and reporting.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shenzhen Zhijun Pharmaceutical Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.